Teacher, mom — and living proof of principle – Fred Hutch News Service
Fred Hutch News Service |
Teacher, mom — and living proof of principle
Fred Hutch News Service Tiffany O’Keefe, photographed recently with her three children, participated in a clinical trial of an experimental immunotherapy to treat her advanced synovial sarcoma. While her cancer is still present, it has shrunk significantly since the trial … |
Clinical Pain Advisor (registration) |
Stem Cell Therapy for Pain Management
Clinical Pain Advisor (registration) LAS VEGAS – In a presentation at PAINWeek 2017, held September 5-9, Jay Joshi, MD, CEO and medical director of the National Pain Centers in Vernon Hills, Illinois, gave on overview of stem cell therapies used in regenerative medicine to treat a number … |
MIT Technology Review |
Amid Setback, Researchers Forge Ahead with “Off-the-Shelf” Immune Cells to Treat Cancer
MIT Technology Review The highly personalized treatment, called CAR–T therapy, uses a patient’s own immune cells and takes about three weeks to manufacture—two factors that lend to its $475,000 price tag. Similar therapies are in the pipeline, but the cost and time it … |
MIT Technology Review |
Patient Death Won’t Slow Research on “Off-the-Shelf” Immune Cells to Treat Cancer
MIT Technology Review The highly personalized treatment, called CAR–T therapy, uses a patient’s own immune cells and takes about three weeks to manufacture—two factors that lend to its $475,000 price tag. Similar therapies are in the pipeline, but the cost and time it … |
|
THERE’S A NEW STEM CELL SHERIFF IN TOWN
Bloomberg BNA Tough words from new FDA Commissioner Scott Gottlieb last week to describe stem cell clinics that have popped up around the country and, according to the agency, peddle unapproved, unproven, and even dangerous regenerative medicine products. |
Cancer Research UK |
Viruses may boost immunotherapy success
Cancer Research UK It’s thought that viruses could be used to increase the proportion of patients who respond to immunotherapy drugs by drawing the attention of the immune system to the cancer. “They see that there’s an increase in the ‘heat’ of the tumour when the virus … |
|
Cancer Immunotherapy May Be Improved If Tregs Are Deftly Impaired
Genetic Engineering & Biotechnology News The balancing act that is cancer immunotherapy requires that the body’s antitumor response be given a boost, but not too much of a boost. For example, simply getting rid of Tregs, the regulatory T cells that moderate the immune system’s attack on … |
|
Cancer Immunotherapy Developers Raise Nearly $150M in Financing
Genetic Engineering & Biotechnology News A pair of cancer immunotherapy developers have raised a combined nearly $150 million in Series B financings toward development of new platform technologies, treatments, and facilities. Gritstone Oncology, which aims initially to develop tumor-specific … |